Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

2017-09-12

Opinion for Johnson & Johnson (JNJ-N)

Signal Price Bias Subject Owned
PAST TOP PICK $132.630 BULLISH NORTH AMERICAN - LARGE Yes

(A Top Pick Sept 13/16. Up 16%.) Still likes this. Their pharmaceutical division, consumer products division and medical device division all play into an aging demographics. The pharmaceutical division is doing quite well right now. Has a lot of new products that are doing well. She sees decent earnings growth in the high single digits range. Very strong balance sheet. Pays a dividend of just over 2%, and has increased the dividend for the last 56 years.

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management

No Comments.


You must be logged in to comment.